Adicet Bio, Inc. Share Price
ACETAdicet Bio, Inc. Stock Performance
Open $8.58 | Prev. Close $8.57 | Circuit Range N/A |
Day Range $8.50 - $8.79 | Year Range $0.46 - $9.38 | Volume 7,365 |
Average Traded $8.64 |
Adicet Bio, Inc. Share Price Chart
About Adicet Bio, Inc.
Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. It offers gamma delta T cells engineered with chimeric antigen receptors (CARs) to facilitate durable activity in patients. The company's lead product candidate is ADI-001, an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, which is in Phase I clinical trial for the potential treatment of autoimmune diseases and relapsed/refractory B-cell non-hodgkin's lymphoma. It also develops ADI-270, an armored gamma delta CAR T cell product candidate to treat multiple CD70+ solid tumor and hematological malignancies indications, with renal cell carcinoma. The company was founded in 2014 and is based in Boston, Massachusetts.
Adicet Bio, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
30-Jun-26 | $8.58 | $8.63 | +0.00% |
30-Jun-26 | $8.58 | $8.63 | +0.70% |
29-Jun-26 | $8.44 | $8.57 | +2.88% |
26-Jun-26 | $8.15 | $8.33 | +4.32% |
25-Jun-26 | $8.29 | $7.99 | -3.80% |
24-Jun-26 | $8.39 | $8.30 | +1.47% |
23-Jun-26 | $8.28 | $8.18 | -0.73% |